Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients
- 1 October 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (10) , 2115-2121
- https://doi.org/10.1038/sj.leu.2402675
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 19 references indexed in Scilit:
- Early Relapse After High-Dose Chemotherapy Rescued by Tumor-Free Autologous Peripheral Blood Stem Cells in Acute Lymphoblastic Leukemia: Importance of Monitoring for WT1-mRNA QuantitativelyLeukemia & Lymphoma, 2001
- The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantationBone Marrow Transplantation, 2000
- Wilms' Tumor Gene Expression by Normal and Malignant Human B LymphocytesLeukemia & Lymphoma, 2000
- Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual diseaseLeukemia, 1999
- Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic LeukemiaBlood, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- The Wilms tumour gene WT1 is expressed in murine mesoderm–derived tissues and mutated in a human mesotheliomaNature Genetics, 1993
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990
- High gradient magnetic cell separation with MACSCytometry, 1990